SJOGREN'S SYNDROME (SS)

Clinical trials for SJOGREN'S SYNDROME (SS) explained in plain language.

Never miss a new study

Get alerted when new SJOGREN'S SYNDROME (SS) trials appear

Sign up with your email to follow new studies for SJOGREN'S SYNDROME (SS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1

Experimental cell infusion aims to tame childhood autoimmune diseases

Disease control Not yet recruiting

This early-stage trial will test a new cell therapy called YTS109 in 12 children aged 5 to 17 with severe autoimmune diseases like lupus or scleroderma that have not responded to standard treatments. The children will receive a single infusion of these cells, and researchers will…

Matched conditions: SJOGREN'S SYNDROME (SS)

Phase: PHASE1 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control

Last updated Jun 27, 2026 09:09 UTC

SJOGREN'S SYNDROME (SS)

Get alerted when new SJOGREN'S SYNDROME (SS) trials appear

Experimental cell infusion aims to tame childhood autoimmune diseases